G1 Therapeutics, Inc.
G1 Therapeutics, Inc.（GTHX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · GTHX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
34
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
G1 Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
GTHX 季度内部人买卖趋势
GTHX 内幕交易卖出 · GTHX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
GTHX 高管卖出股份 · GTHX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 18, 2024 | Secor Alicia Director | Other | 20,000 | $143K | Form 4 |
| Sep 18, 2024 | Secor Alicia Director | Other | 10,000 | — | Form 4 |
| Sep 18, 2024 | Thomas Monica R. Chief Legal & People Officer | Other | 138,151 | $988K | Form 4 |
| Sep 18, 2024 | Thomas Monica R. Chief Legal & People Officer | Other | 6,674 | — | Form 4 |
| Sep 18, 2024 | Flowers Cynthia Louise Director | Other | 20,000 | $143K | Form 4 |
| Sep 18, 2024 | Flowers Cynthia Louise Director | Other | 15,889 | — | Form 4 |
| Sep 18, 2024 | Nicholson Garry A Director | Other | 20,000 | $143K | Form 4 |
| Sep 18, 2024 | Lee Jacks Director | Other | 10,000 | $72K | Form 4 |
| Sep 18, 2024 | Nicholson Garry A Director | Other | 14,389 | — | Form 4 |
| Sep 18, 2024 | Lee Jacks Director | Other | 10,000 | — | Form 4 |
| Sep 18, 2024 | Bailey John E. (Jack) Jr. President and CEO · Director | Award | 181,400 | — | Form 4 |
| Sep 18, 2024 | Bailey John E. (Jack) Jr. President and CEO · Director | Other | 534,787 | $3.82M⚡ | Form 4 |
| Sep 18, 2024 | Umstead John W. V CFO | Other | 168,387 | $1.20M⚡ | Form 4 |
| Sep 18, 2024 | Bailey John E. (Jack) Jr. President and CEO · Director | Other | 196,287 | — | Form 4 |
| Sep 18, 2024 | Umstead John W. V CFO | Other | 19,331 | — | Form 4 |
| Sep 18, 2024 | Malik Rajesh Chief Medical Officer | Award | 17,900 | — | Form 4 |
| Sep 18, 2024 | Malik Rajesh Chief Medical Officer | Other | 89,762 | $642K | Form 4 |
| Sep 18, 2024 | Malik Rajesh Chief Medical Officer | Other | 87,450 | — | Form 4 |
| Sep 18, 2024 | Avagliano Mark Chief Business Officer | Award | 20,600 | — | Form 4 |
| Sep 18, 2024 | Avagliano Mark Chief Business Officer | Other | 236,610 | $1.69M⚡ | Form 4 |
| Sep 18, 2024 | Avagliano Mark Chief Business Officer | Other | 26,035 | — | Form 4 |
| Sep 18, 2024 | Sharpless Norman Director | Other | 20,000 | $143K | Form 4 |
| Sep 18, 2024 | MURDOCK TERRY L COO | Award | 17,900 | — | Form 4 |
| Sep 18, 2024 | MURDOCK TERRY L COO | Other | 124,762 | $892K | Form 4 |
| Sep 18, 2024 | MURDOCK TERRY L COO | Other | 21,150 | — | Form 4 |
Thomas Monica R.
Chief Legal & People Officer
日期
Sep 18
股数
138,151
均价
$7.15
总金额
$988K
Bailey John E. (Jack) Jr.
President and CEO · Director
日期
Sep 18
股数
181,400
均价
—
总金额
—
Bailey John E. (Jack) Jr.
President and CEO · Director
日期
Sep 18
股数
534,787
均价
$7.15
总金额
$3.82M ⚡
Bailey John E. (Jack) Jr.
President and CEO · Director
日期
Sep 18
股数
196,287
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 GTHX 内幕交易
GTHX 内幕交易
G1 Therapeutics, Inc.（GTHX）内幕交易数据来源于公司内部人（包括GTHX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。GTHX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看G1 Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
GTHX 内幕交易 · 5个问题G1 Therapeutics, Inc.（GTHX）的内部人包括高管和董事，如GTHX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026